Suture line administration technique using botulinum toxins | Patent Number 10874722

US 10874722 B2
Application Number16291383
Publication NumberUS 20190240299 A1
Pendency1 year, 10 months, 1 day
Filled DateMar 4, 2019
Priority DateApr 3, 2008
Publication DateAug 8, 2019
Expiration DateApr 2, 2028
Inventor/ApplicantsAndrew M. Blumenfeld
ExaminesMINNIFIELD, NITA M
Art Unit1645
Technology Center1600
Assignments
Allergan
Current
AllerganAbbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.